open access

Vol 2, No 1 (2011)
Review paper
Published online: 2011-03-24
Get Citation

Treatment of chronic myeloid leukemia in pregnant women

Joanna Góra-Tybor
Hematologia 2011;2(1):57-62.

open access

Vol 2, No 1 (2011)
REVIEW ARTICLES
Published online: 2011-03-24

Abstract

Introducing BCR-ABL1 tyrosine kinase inhibitors (TKI) dramatically improved the survival of patients with chronic myeloid leukemia (CML). Tolerance of treatment is very good as well as patients have high quality of life and expectations, including fertility and procreation. Animal data suggest that TKI are teratogenic for fetus. The data relating to children born to women exposed to imatinib (IM) during pregnancy indicate an occurrence of rare congenital malformation, such that IM cannot be recommended during pregnancy, particularly within a period of organogenesis. Alternative strategies of CML treatment, including leukapheresis and interferon alfa, are thus recommended. In contrast children born to men taking IM seem healthy and current advice is not to interrupt treatment.
Hematologia 2011; 2, 1: 57–62

Abstract

Introducing BCR-ABL1 tyrosine kinase inhibitors (TKI) dramatically improved the survival of patients with chronic myeloid leukemia (CML). Tolerance of treatment is very good as well as patients have high quality of life and expectations, including fertility and procreation. Animal data suggest that TKI are teratogenic for fetus. The data relating to children born to women exposed to imatinib (IM) during pregnancy indicate an occurrence of rare congenital malformation, such that IM cannot be recommended during pregnancy, particularly within a period of organogenesis. Alternative strategies of CML treatment, including leukapheresis and interferon alfa, are thus recommended. In contrast children born to men taking IM seem healthy and current advice is not to interrupt treatment.
Hematologia 2011; 2, 1: 57–62
Get Citation

Keywords

chronic myeloid leukemia; tyrosine kinase inhibitors; imatinib; dasatinib; nilotinib; pregnancy

About this article
Title

Treatment of chronic myeloid leukemia in pregnant women

Journal

Hematology in Clinical Practice

Issue

Vol 2, No 1 (2011)

Article type

Review paper

Pages

57-62

Published online

2011-03-24

Bibliographic record

Hematologia 2011;2(1):57-62.

Keywords

chronic myeloid leukemia
tyrosine kinase inhibitors
imatinib
dasatinib
nilotinib
pregnancy

Authors

Joanna Góra-Tybor

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.